Clinical trial Recruiting at 11 sites Interventional Ages 65 and up

Accelerated rehabilitation for rotator cuff tears using the InSpace device

Official title: An Assessment of Two Accelerated Rehabilitation Programs for Use With the InSpaceTM Subacromial Tissue Spacer System in the Treatment of Full-thickness Massive, Irreparable Rotator Cuff Tears

Run by Stryker Endoscopy · NCT05329584 · Data updated 2026-11-12

This study is testing two different rehab programs for people with serious rotator cuff tears who have had surgery using the InSpace device to see which one helps them recover better.

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment160 (estimated)
SponsorStryker Endoscopy
Industry-sponsored
Locations11 sites (Phoenix, Arizona and 10 other locations)
StatusRecruiting
StartedFebruary 7, 2022
Main results expectedApril 2026
Study endsDecember 2026
Registry record updatedMay 29, 2025
Trial IDNCT05329584 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 65 and older with a confirmed diagnosis of full thickness MRCT who have failed non-operative treatments.

Probably not a fit

Patients with rotator cuff tears that do not meet the specified criteria or those who have not failed prior non-operative treatments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates two accelerated rehabilitation programs for patients with full thickness Massive, Irreparable Rotator Cuff Tears (MIRCTs) who have undergone an arthroscopic procedure using the InSpace device. It is a prospective, parallel group, open-label, multi-center, randomized study that aims to assess clinical outcomes of both a formalized rehabilitation program and an at-home program. The study will compare these outcomes to historical control results from the InSpace pivotal study and analyze changes in clinical outcomes from baseline. Participants will be monitored for their recovery progress and overall effectiveness of the rehabilitation approaches.

Why it matters

Potential benefit: If successful, this study could provide improved rehabilitation strategies for patients with severe rotator cuff injuries, potentially leading to better recovery outcomes.

How similar studies have gone: Other studies have shown promise in using innovative rehabilitation techniques for rotator cuff injuries, but this specific approach with the InSpace device is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Subjects MUST meet ALL the following criteria to be included in the study:

* The subject has signed the IRB approved Informed Consent Form (ICF) specific to this study prior to enrollment
* Is male or female ≥ sixty-five (65) years of age
* Positive diagnostic imaging by MRI within 9 months of enrollment of the index shoulder indicating a full thickness MRCT:

  * Measuring ≥ 5 cm in diameter
  * Involving ≥ two tendons
* Functional deltoid muscle and preserved passive range of motion on physical examination
* Documented VAS score \> 30 mm pain
* Failed non-operative treatment of at least 3 months from the initial treatment to include one or more of the following:

  * Oral analgesics
  * Anti-inflammatory medication (e.g., ibuprofen, naproxen)
  * Corticosteroid injection(s)
  * Physical therapy
  * Activity modification
  * Rest (sling used)
* Must be able to read and understand the approved Informed Consent Form (written and oral)
* Must be in general good health (as determined by the Investigator) based on screening assessments and medical history
* Must be independent, ambulatory, and can comply with all post-operative evaluations, visits, and electronic database collection

Intra-operative Inclusion Criteria

Subjects MUST meet the following criteria to be randomized in the study:

* Full thickness tear
* Tear size ≥ 5 cm in diameter
* Tear involving ≥ two tendons

Exclusion Criteria:

Subjects will be excluded from the study, if they meet ANY of the following individual exclusion criteria:

* Known allergy to the device material (copolymer of PLA (poly (lactic acid) and -ε-caprolactone)
* Evidence of the following conditions:

  * Severe gleno-humeral or acromio-humeral arthritis
  * Full thickness cartilage loss as seen on MRI
  * History within the past 5 years of anterior or posterior shoulder subluxation or dislocation as determined by history, examination, or radiographic findings
  * Pre-existing deltoid defect or deltoid palsy
  * Major joint trauma, infection, or necrosis
  * Partial thickness tears of the supraspinatus
  * Fully reparable rotator cuff tear \[Tear of less than 5 cm in diameter (or \< 4 cm2) with retractable tendon that can be fully repaired\]
  * Known neurovascular compromise
  * Complete deltoid muscle palsy
  * Traumatic muscle tears of the pectoralis or deltoid
* The subject requires concomitant:

  * Subscapularis repair
  * Labral repair of any type
  * Biceps tenodesis
* Previous surgery of the index shoulder in the past 1 year, excluding diagnostic arthroscopy
* The subject's condition is bilateral and rotator cuff repair is scheduled or to be scheduled over the course of this study for the contra lateral shoulder
* Major medical condition that could affect quality of life and influence the results of the study (e.g., rheumatoid arthritis)
* The subject has documented evidence of a history (e.g., liver testing) of drug/alcohol abuse within 12 months of enrollment
* The subject's condition represents a worker's compensation case
* The subject is currently involved in a health-related litigation procedure
* Females of child-bearing potential who are pregnant or plan to become pregnant.
* Concurrent participation in an investigational clinical study one month prior to enrollment or during the entire study period
* The subject is physically or mentally compromised (e.g., currently being treated for a psychiatric disorder, senile dementia, Alzheimer's disease, etc.), to the extent that the Investigator judges the subject to be unable or unlikely to remain compliant to follow-up
* The subject is receiving prescription narcotic pain medication for conditions unrelated to the index shoulder condition
* The subject currently has an acute infection in the area surrounding the surgical site.
* Baseline WORC score less than 420

Intra-operative Exclusion Criteria:

Subjects will not be randomized and will be terminated from the study if they meet ANY of the following individual intra-operative exclusion criteria:

* Rotator cuff is/presents with:

  * Fully reparable with adequate tissue and muscle quality (equivalent to Goutallier stage 1 or 2)
  * Partial thickness tear of the supraspinatus
  * Evidence of significant osteoarthritis
* The subject requires concomitant:

  * Subscapularis repair
  * Labral repair of any type
  * Biceps tenodesis
* Coracoacromial ligament functional deficiency or shoulder instability is identified

Where it's running

  • Musculoskeletal-Orthopedic Research and Education Foundation
    Phoenix, Arizona, United States
    Recruiting
  • University of Arkansas for Medical Sciences
    Little Rock, Arkansas, United States
    Recruiting
  • Steadman Hawkins Clinic Denver
    Englewood, Colorado, United States
    Recruiting
  • Holy Cross Hospital
    Fort Lauderdale, Florida, United States
    Recruiting
  • Paley Orthopaedics & Spine
    West Palm Beach, Florida, United States
    Recruiting
  • Emory University
    Atlanta, Georgia, United States
    Recruiting
Show 5 more locations
  • Rush University Medical Center
    Chicago, Illinois, United States
    Recruiting
  • Mayo Clinic
    Rochester, Minnesota, United States
    Recruiting
  • Hospital for Special Surgery
    New York, New York, United States
    Recruiting
  • The Rothman Institute
    Philadelphia, Pennsylvania, United States
    Recruiting
  • TSAOG Orthopaedics & Spine
    San Antonio, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.